iBio, Inc. - Common Stock, par value $0.001 per share (IBIO)
CUSIP: 451033708
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 30,719,795
- Total 13F shares
- 2,885,311
- Share change
- +2,633,425
- Total reported value
- $11,469,753
- Price per share
- $4.06
- Number of holders
- 26
- Value change
- +$10,566,308
- Number of buys
- 13
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 451033708?
CUSIP 451033708 identifies IBIO - iBio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 451033708:
Top shareholders of IBIO - iBio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.58%
|
176,748
|
$242,145 | — | 31 Dec 2023 | |
| Randy Joe Maddux |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
271,757
|
$72,151 | — | 07 Dec 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.08%
|
25,387
|
$34,780 | — | 31 Dec 2023 | |
| Robert Matthew Lutz |
3/4/5
|
Chief Financial & Business Officer and Principal Accounting Officer |
—
class O/S missing
|
102,165
|
$27,125 | — | 11 Nov 2022 | |
| Warberg Asset Management LLC |
13F
|
Company |
0.06%
|
19,000
|
$26,220 | — | 31 Dec 2023 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
18,000
|
$24,660 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
6,887
|
$9,435 | — | 31 Dec 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
4,783
|
$6,553 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
339
|
$464 | — | 31 Dec 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
58
|
$79 | — | 31 Dec 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
50
|
$69 | — | 31 Dec 2023 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
42
|
$58 | — | 31 Dec 2023 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
40
|
$55 | — | 31 Dec 2023 | |
| Retirement Group, LLC |
13F
|
Company |
0%
|
14
|
$19 | — | 31 Dec 2023 | |
| SOA Wealth Advisors, LLC. |
13F
|
Company |
0%
|
13
|
$18 | — | 31 Dec 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
12
|
$16 | — | 31 Dec 2023 | |
| CITY HOLDING CO |
13F
|
Company |
0%
|
4
|
$5 | — | 31 Dec 2023 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
3
|
$4 | — | 31 Dec 2023 | |
| Financial Gravity Asset Management, Inc. |
13F
|
Company |
0%
|
2
|
$3 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2
|
$3 | — | 31 Dec 2023 | |
| Arax Advisory Partners |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Dec 2023 | |
| Planned Solutions, Inc. |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Dec 2023 | |
| Thomas F. Isett |
3/4/5
|
CEO and Executive Chairman, Director |
—
class O/S missing
|
2,000,000
|
— | — | 08 Sep 2022 | |
| General Hill (ret) James T. |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 | |
| Glenn Chang |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 | |
| John D. McKey Jr. |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 | |
| Linda Washington Armstrong |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 |
Institutional Holders of iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) as of Q1 2024
As of 31 Mar 2024,
iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,885,311 shares.
The largest 10 holders included
Opaleye Management Inc., Ikarian Capital, LLC, ADAR1 Capital Management, LLC, Lynx1 Capital Management LP, ARMISTICE CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, SABBY MANAGEMENT, LLC, FNY Investment Advisers, LLC, BlackRock Inc., and Tower Research Capital LLC (TRC).
This page lists
26
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
20
Q1 2024 holders
26
Holder diff
6
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.